ANDA Sponsors Get Wide-Open Facility Deadline For Priority Review

User fee legislation says facility information to qualify for priority review must arrive two months in advance of ANDA, conflicting with narrow 'window' in FDA's draft guidance.

FDA entrance sign 2016

More from Generics

More from Biosimilars & Generics